J Volavka

Summary

Affiliation: Nathan Kline Institute
Country: USA

Publications

  1. ncbi Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
    Jan Volavka
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10982, USA
    Am J Psychiatry 159:255-62. 2002
  2. ncbi Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol
    Jan Volavka
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10982, USA
    J Clin Psychopharmacol 24:225-8. 2004
  3. ncbi Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies
    Jan Volavka
    The Nathan Kline Institute and New York University, 140 Old Orangeburg Road, Orangeburg, N Y 10962, USA
    J Clin Psychiatry 66:1362-6. 2005
  4. ncbi COMT158 polymorphism and hostility
    Jan Volavka
    Nathan Kline Institute, Orangeburg, New York 10982, USA
    Am J Med Genet B Neuropsychiatr Genet 127:28-9. 2004
  5. ncbi Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol
    Jan Volavka
    Nathan Kline Institute, Orangeburg, NY 10982, USA
    J Clin Psychiatry 65:57-61. 2004
  6. ncbi Catecholamines and aggression: the role of COMT and MAO polymorphisms
    Jan Volavka
    Nathan Kline Institute, 140 Old Orangeburg Road, Orangeburg, New York 10962, USA
    Ann N Y Acad Sci 1036:393-8. 2004
  7. ncbi Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concerns
    J Volavka
    New York University, Department of Psychiatry, Nathan Kline Institue for Psychiatric Research, Orangeburg 10962, USA
    Schizophr Res 35:S23-33. 1999
  8. ncbi The neurobiology of violence: an update
    J Volavka
    Nathan Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    J Neuropsychiatry Clin Neurosci 11:307-14. 1999
  9. ncbi Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia
    L Citrome
    Nathan Kline Institute for Psychiatric Research in Orangeburg, New York 10962, USA
    Psychiatr Serv 52:1510-4. 2001
  10. ncbi Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder
    H M Lachman
    Department of Psychiatry and Medicine, Albert Einstein College of Medicine, Orangeburg, N Y, USA
    Am J Psychiatry 155:835-7. 1998

Detail Information

Publications61

  1. ncbi Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder
    Jan Volavka
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10982, USA
    Am J Psychiatry 159:255-62. 2002
    ....
  2. ncbi Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol
    Jan Volavka
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10982, USA
    J Clin Psychopharmacol 24:225-8. 2004
    ..Clozapine appears to have superior antiaggresive effects in treatment-resistant patients; this superiority develops after the patient has been exposed to an adequate dose regimen...
  3. ncbi Efficacy of aripiprazole against hostility in schizophrenia and schizoaffective disorder: data from 5 double-blind studies
    Jan Volavka
    The Nathan Kline Institute and New York University, 140 Old Orangeburg Road, Orangeburg, N Y 10962, USA
    J Clin Psychiatry 66:1362-6. 2005
    ..The objective was to determine the effects of aripiprazole on hostility...
  4. ncbi COMT158 polymorphism and hostility
    Jan Volavka
    Nathan Kline Institute, Orangeburg, New York 10982, USA
    Am J Med Genet B Neuropsychiatr Genet 127:28-9. 2004
    ..The Met-Met homozygotes (N = 7) were found to have significantly higher levels of hostility than the other patients (N = 53). The hypothesis was thus supported. The finding should be replicated in a larger sample...
  5. ncbi Prolactin levels in schizophrenia and schizoaffective disorder patients treated with clozapine, olanzapine, risperidone, or haloperidol
    Jan Volavka
    Nathan Kline Institute, Orangeburg, NY 10982, USA
    J Clin Psychiatry 65:57-61. 2004
    ....
  6. ncbi Catecholamines and aggression: the role of COMT and MAO polymorphisms
    Jan Volavka
    Nathan Kline Institute, 140 Old Orangeburg Road, Orangeburg, New York 10962, USA
    Ann N Y Acad Sci 1036:393-8. 2004
    ..Collectively, these results suggest that COMT and MAOA polymorphisms represent a basic neurobiological mechanism that contributes to the regulation of aggressive behavior...
  7. ncbi Atypical antipsychotics in the treatment of the persistently aggressive psychotic patient: methodological concerns
    J Volavka
    New York University, Department of Psychiatry, Nathan Kline Institue for Psychiatric Research, Orangeburg 10962, USA
    Schizophr Res 35:S23-33. 1999
    ..g. randomization) used in typical designs of psychopharmacological clinical trials. Current research methods should be modified and new ones developed in order to progress in assessing the antiaggressive effects of treatments...
  8. ncbi The neurobiology of violence: an update
    J Volavka
    Nathan Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    J Neuropsychiatry Clin Neurosci 11:307-14. 1999
    ..Progress in the prevention and management of violent behavior depends on studies that address biological factors in their social context. This article updates a previous review...
  9. ncbi Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia
    L Citrome
    Nathan Kline Institute for Psychiatric Research in Orangeburg, New York 10962, USA
    Psychiatr Serv 52:1510-4. 2001
    ..This study compared the specific antiaggressive effects of clozapine with those of olanzapine, risperidone, and haloperidol...
  10. ncbi Association between catechol O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder
    H M Lachman
    Department of Psychiatry and Medicine, Albert Einstein College of Medicine, Orangeburg, N Y, USA
    Am J Psychiatry 155:835-7. 1998
    ..This study replicates and extends these findings by using more direct measures of violent behavior...
  11. ncbi Suicidal behavior in patients with schizophrenia is related to COMT polymorphism
    K A Nolan
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    Psychiatr Genet 10:117-24. 2000
    ..These findings support a common neurobiological substrate for self- and other-directed aggression, and suggest that catecholaminergic alterations may contribute to these behaviors in schizophrenic and schizoaffective patients...
  12. doi Heterogeneity of violence in schizophrenia and implications for long-term treatment
    J Volavka
    Department of Psychiatry, New York University School of Medicine, New York, NY, USA
    Int J Clin Pract 62:1237-45. 2008
    ..The aim of this review is to address the subtyping of violent behaviour in schizophrenia, and to relate the subtypes to treatment...
  13. ncbi Acute mania: haloperidol dose and augmentation with lithium or lorazepam
    J C Chou
    Nathan Kline Institute, Orangeburg, New York 10962, USA
    J Clin Psychopharmacol 19:500-5. 1999
    ..Lorazepam 4 mg/day was insufficient to produce an advantage when added to low-dose haloperidol...
  14. ncbi An association between a polymorphism of the tryptophan hydroxylase gene and aggression in schizophrenia and schizoaffective disorder
    K A Nolan
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    Psychiatr Genet 10:109-15. 2000
    ..These results tend to support previous reports by New et al. (1996; 1998) of an association between the TPH L allele and impulsive aggression in males with personality disorder, but larger studies are needed...
  15. ncbi Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder
    J C Chou
    Nathan Kline Institute, Orangeburg, NY 10962, USA
    Psychiatry Res 81:51-5. 1998
    ..Further study of prolactin and clinical response to typical neuroleptics should focus on low neuroleptic doses...
  16. ncbi Psychopathy and violent behavior among patients with schizophrenia or schizoaffective disorder
    K A Nolan
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Psychiatr Serv 50:787-92. 1999
    ..Patients with and without a history of persistent violent behavior were compared for comorbidity of psychopathy and schizophrenia or schizoaffective disorder...
  17. ncbi Haloperidol blood levels in acute mania with psychosis
    J C Chou
    Nathan Kline Institute, Orangeburg, New York 10962, USA
    J Clin Psychopharmacol 21:445-7. 2001
    ..Haloperidol blood levels may be clinically useful in identifying patients who are nonresponsive because of low drug levels and, hence, in enhancing optimal haloperidol dosing for acute mania with psychosis...
  18. ncbi IQ scores of treatment-resistant schizophrenia patients before and after the onset of the illness
    B B Sheitman
    Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA
    Schizophr Res 46:203-7. 2000
    ..807, P < 0.0001), while duration of illness (10-40 years) was unrelated to the magnitude of IQ score decline (r = -0.103, P = 0.575). These data suggest that pre-morbid IQ test scores are highly predictive of post-morbid scores...
  19. ncbi Violent patients in the emergency setting
    L Citrome
    Department of Psychiatry, New York University, New York, USA
    Psychiatr Clin North Am 22:789-801. 1999
    ..The use of typical neuroleptics may lead to side effects, such as akathisia, which may in turn precipitate additional agitation. This may be obviated with the introduction of IM preparations of atypical antipsychotics...
  20. ncbi Olanzapine for schizophrenia refractory to typical and atypical antipsychotics: an open-label, prospective trial
    J P Lindenmayer
    Psychopharmacology Research Unit, Manhattan Psychiatric Unit, Manhattan Psychiatric Center, Wards Island, New York 10035, USA
    J Clin Psychopharmacol 21:448-53. 2001
    ..However, a trial with olanzapine can be recommended in these patients before moving to augmentation strategies, given the lack of proven alternatives and the observation that 16.7% of patients reached the response criteria...
  21. ncbi Update on the biological treatment of aggression
    J Volavka
    Nathan S Kline Institute for Psychiatric Research, New York University, USA
    Actas Esp Psiquiatr 34:123-35. 2006
    ..The heterogeneity of aggressive behavior is a challenge for developing rational treatments. Emerging genetic findings hold a promise of future treatments of aggressive behavior developed on the basis of individual patients' genotypes...
  22. ncbi Efficacy of ziprasidone against hostility in schizophrenia: Post hoc analysis of randomized, open-label study data
    Leslie Citrome
    Nathan S Kline Institute for Psychiatric Research and the New York University School of Medicine, Orangeburg, NY 10962, USA
    J Clin Psychiatry 67:638-42. 2006
    ..The objective was to determine the effects of sequential intramuscular/oral ziprasi-done on hostility...
  23. ncbi Video recording in the assessment of violent incidents in psychiatric hospitals
    Karea A Nolan
    Nathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    J Psychiatr Pract 12:58-63. 2006
    ..The ethical and responsible use of video surveillance of psychiatric inpatients has the potential to enhance our understanding and treatment of aggression...
  24. pmc Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder
    Matthew J Hoptman
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Psychiatry Res 140:133-45. 2005
    ..Larger left OFC gray matter volumes and larger OFC white matter volumes bilaterally were associated with greater levels of aggression. These findings are discussed in the context of potential iatrogenic effects...
  25. ncbi Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO)
    Istvan Bitter
    Department of Psychiatry and Psychotherapy, Semmelweis University, Balassa u 6, 1083 Budapest, Hungary
    Eur Psychiatry 20:403-8. 2005
    ..Antipsychotic medications may reduce hostile and aggressive behavior in schizophrenia. This study compared the effectiveness of antipsychotics in the treatment of aggression...
  26. ncbi A cognitive, behaviorally based program for patients with persistent mental illness and a history of aggression, crime, or both: structure and correlates of completers of the program
    Kathy Yates
    New York University School of Medicine and Manhattan Psychiatric Center, Ward s Island Complex, NY 10035, USA
    J Am Acad Psychiatry Law 33:214-22. 2005
    ..In comparison with the 91 who did not complete the program, those who did were less cognitively impaired and less impulsive. We present a new, intensive treatment program and define the predictors of successful completion of the program...
  27. ncbi Suggestive association between the C825T polymorphism of the G-protein beta3 subunit gene (GNB3) and clinical improvement with antipsychotics in schizophrenia
    Daniel J Muller
    Neurogenetics Section, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada
    Eur Neuropsychopharmacol 15:525-31. 2005
    ..8 to 7%. Our results further suggest that this effect is only attributable to Caucasians when compared to African-Americans. Moreover, our findings point to the role of intracellular mechanisms in antipsychotic response...
  28. ncbi Catechol-O-methyltransferase and monoamine oxidase-A polymorphisms and treatment response to typical and atypical neuroleptics
    Karen A Nolan
    J Clin Psychopharmacol 26:338-40. 2006
  29. pmc Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia
    Jeffrey W Swanson
    Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, 905 West Main Street, Durham, NC 27710, USA
    Br J Psychiatry 193:37-43. 2008
    ..Violence is an uncommon but significant problem associated with schizophrenia...
  30. ncbi Are all antipsychotics equal?
    Jan Volavka
    Lancet 372:201-2; author reply 202. 2008
  31. doi Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose study
    Bruce J Kinon
    Eli Lilly and Company, Lilly Corporate Center, Drop Code 4133, Indianapolis, IN 46285, USA
    J Clin Psychopharmacol 28:392-400. 2008
    ....
  32. ncbi Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials
    Donald C Goff
    Massachusetts General Hospital, Harvard Medical School, 25 Staniford Street, Boston, MA 02114, USA
    J Clin Psychopharmacol 27:582-9. 2007
    ..We sought to evaluate the potential role of lamotrigine augmentation in schizophrenia patients resistant to atypical antipsychotic medication...
  33. ncbi Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility
    Leslie Citrome
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    Int Clin Psychopharmacol 22:356-62. 2007
    ..In conclusion, although patients receiving combination treatment were more likely to complete the study, we were unable to detect a meaningful advantage for combination therapy as measured by rating scales...
  34. ncbi HTR2C haplotypes and antipsychotics-induced weight gain: X-linked multimarker analysis
    Vincenzo De Luca
    Department of Psychiatry, Centre for Addiction and Mental Health, Neurogenetics Section, University of Toronto, Toronto, ON, Canada
    Hum Psychopharmacol 22:463-7. 2007
    ....
  35. pmc Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder
    Matthew J Hoptman
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    J Neuropsychiatry Clin Neurosci 18:509-15. 2006
    ..The relationship between aggression and caudate volumes may be related to the iatrogenic effects of long-term treatment with typical antipsychotic agents or to a direct effect of schizophrenic processes on the caudate...
  36. ncbi Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication
    Gwyneth Zai
    Neurogenetics Section, Centre for Addiction and Mental Health, Toronto, Canada
    Psychopharmacology (Berl) 188:171-82. 2006
    ..3, a region that has been found to be associated with SCZ in numerous linkage studies. One functional polymorphism, G-308A, has been studied for association with SCZ yielding inconsistent findings...
  37. pmc Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study
    Jari Tiihonen
    Department of Forensic Psychiatry, University of Kuopio, Niuvanniemi Hospital, FIN 70240 Kuopio, Finland
    BMJ 333:224. 2006
    ..To study the association between prescribed antipsychotic drugs and outcome in schizophrenia or schizoaffective disorder in the community...
  38. ncbi Efficacy of clozapine, olanzapine, risperidone, and haloperidol in schizophrenia and schizoaffective disorder assessed with nurses observation scale for inpatient evaluation
    Jan Volavka
    Schizophr Res 76:127-9. 2005
  39. ncbi The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia
    Daniel J Muller
    Neurogenetics Section, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, 250 College Street R30, Toronto, Ont M5T 1R8, Canada
    Neurosci Lett 379:81-9. 2005
    ..Weight changes do not seem to be associated with polymorphism of the SNAP-25 gene, however, replication in independent samples is warranted...
  40. ncbi Characteristics of assaultive behavior among psychiatric inpatients
    Karen A Nolan
    Nathan S Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, New York 10962, USA
    Psychiatr Serv 54:1012-6. 2003
    ..The purpose of this study was to assess the extent to which psychosis, disordered impulse control, and psychopathy contribute to assaults among psychiatric inpatients...
  41. ncbi Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility
    Karen A Nolan
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Am J Psychiatry 161:359-61. 2004
    ..They hypothesized that the Val and Met alleles would be associated with deficits in imitation learning and reversal learning, respectively...
  42. ncbi Placebo or active control trials of antipsychotic drugs?
    W Wolfgang Fleischhacker
    Department of Biological Psychiatry, Innsbruck University Clinics, Austria
    Arch Gen Psychiatry 60:458-64. 2003
    ..Sample size requirements for various equivalence margins in noninferiority trials are provided. Scientific and ethical arguments should lead to a more frequent use of the active-control noninferiority trial design...
  43. ncbi Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics
    Jean Pierre Lindenmayer
    Nathan Kline Institute fo Psychiatric Research, New York, NY 10035, USA
    Am J Psychiatry 160:290-6. 2003
    ....
  44. ncbi Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study
    Jean Pierre Lindenmayer
    Psychopharmacology Research Unit, Manhattan Psychiatric Center, Wards Island, NY 10035, USA
    J Clin Psychiatry 63:931-5. 2002
    ....
  45. ncbi Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia
    Robert M Bilder
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Biol Psychiatry 52:701-7. 2002
    ....
  46. ncbi Optimal dosing of atypical antipsychotics in adults: a review of the current evidence
    Leslie Citrome
    Department of Psychiatry, New York University, New York, N Y, USA
    Harv Rev Psychiatry 10:280-91. 2002
    ....
  47. ncbi Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study
    Matthew J Hoptman
    Division of Clinical Research and the Center for Advanced Brain Imaging, Nathan Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    Biol Psychiatry 52:9-14. 2002
    ..Aggression and impulsivity may involve altered frontal white matter...
  48. ncbi Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder
    Robert M Bilder
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA
    Am J Psychiatry 159:1018-28. 2002
    ....
  49. ncbi Antipsychotic-induced weight gain and therapeutic response: a differential association
    Pal Czobor
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    J Clin Psychopharmacol 22:244-51. 2002
    ..These findings suggest that patients who are likely to have the maximal benefits of olanzapine or clozapine treatment for symptom alleviation are at the highest risk of a clinically significant increase in weight gain...
  50. ncbi Olanzapine vs haloperidol for treatment of schizophrenia
    Jan Volavka
    JAMA 291:1064; author reply 1065-6. 2004
  51. ncbi Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia
    Jean Pierre Lindenmayer
    Nathan Kline Institute, Orangeburg, N Y, USA
    J Clin Psychiatry 65:551-6. 2004
    ..We are exploring whether this expanded clinical efficacy can also be seen in patients with treatment-resistant schizophrenia...
  52. ncbi Identification of a naturally occurring 21 bp deletion in alpha 2c noradrenergic receptor gene and cognitive correlates to antipsychotic treatment
    Vincenzo De Luca
    Neurogenetics Section, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, 250 College Street R 30, Toronto, Ont, Canada M5T 1R8
    Pharmacol Res 51:381-4. 2005
    ..Our results suggest that the novel polymorphism may not play a major role in antipsychotic response...
  53. ncbi The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning
    Leslie Citrome
    Nathan S Kline Institute for Psychiatric Research, Orangeburg, New York 10962, USA
    Postgrad Med 116:49-51, 55-9, 63. 2004
    ..In this article, the authors discuss the advantages and side effects of these agents and present a guide to help physicians choose the optimal drug in the most favorable formulation for each patient...
  54. ncbi Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder
    Karen A Nolan
    Nathan Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA
    J Psychiatr Res 39:109-15. 2005
    ..These findings in chronic, treatment resistant inpatients support the view that positive symptoms may lead to aggression...
  55. ncbi The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes
    Robert M Bilder
    Department of Psychiatry, David Geffen School of Medicine and Psychology, UCLA Neuropsychiatric Institute, University of California at Los Angeles, Los Angeles, CA, USA
    Neuropsychopharmacology 29:1943-61. 2004
    ....
  56. ncbi Course of patients with histories of aggression and crime after discharge from a cognitive-behavioral program
    Michael Kunz
    Huntington Department of Veterans Affairs Medical Center, West Virginia, USA
    Psychiatr Serv 55:654-9. 2004
    ..A long-term behaviorally based cognitive skills program was developed and administered to a group of such high-risk inpatients. The authors report the results of a postdischarge follow-up of this group...
  57. ncbi Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement
    Leslie Citrome
    Diabetes Care 27:2087-8; author reply 2089-90. 2004
  58. ncbi Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement
    Leslie Citrome
    J Clin Psychiatry 66:1073-4. 2005
  59. ncbi Genetic linkage for schizophrenia?
    Jan Volavka
    Am J Psychiatry 161:1134-5; author reply 1135-6. 2004
  60. ncbi Screaming and physical aggression in nursing homes
    Nunzio Pomara
    Am J Geriatr Psychiatry 13:539-40. 2005
  61. ncbi Risk for individuals with schizophrenia who are living in the community
    Jan Volavka
    Psychiatr Serv 53:484-5; author reply 485. 2002